← Back to headlines
WHO Prequalifies Novartis’ Coartem Baby for Infant Use
The World Health Organization has prequalified Novartis' Coartem Baby, an antimalarial drug, for use in infants, marking a significant step in combating malaria in young children.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
London's Ultra Low Emission Zone Linked to Improved Children's Lung Health
56m ago
Bayern Munich's Jamal Musiala Reveals Neurological Disorder After On-Field Collapses
2h ago
Sri Lankan Doctors Remove Record-Breaking 3.1kg Bladder Stone
3h ago
Study Links Flight Attendants and Pilots to Higher Cancer Risk
3h ago